| UNC-CH
Heads Together Health
Heads Together Health brings a unique combination of relevant clinical expertise, an innovative technology platform and world class machine learning modeling which can make powerful impacts to patient outcomes. We have designed and developed a concussion management technology solution which …
Couplet Care
Couplet Care, LLC offers tools for improving patient safety and clinical efficiency, while promoting positive mother and infant health outcomes. Our first product, a postnatal unit medical infant bassinet, is a University of North Carolina spin-out, 510(k) Exempt, Class II …
Mizar Therapeutics
Mizar Therapeutics is a platform therapeutics company using proprietary live-cell single-molecule imaging and machine-learning technology for discovery of a new class of targeted cancer therapies. Founders: Paul Maddox, Joel Smith
CollectiveGood
CollectiveGood is a social enterprise with the mission of scaling access to quality health services through digital platforms. CollectiveGood works with partners around the world to research, develop, and deploy digital infrastructure to effectively mobilize health resources and empower community-driven …
VETTA Solutions
VETTA Solutions designs and develops first-in-market devices and applications for detecting, monitoring, and treating conditions that impede healthy human movement. Our inaugural product is a low-cost and clinically-feasible wearable sensor-based system that leverages artificial intelligence and cloud computing for the …
Delgen Biosciences
Delgen Biosciences strives to develop next-generation drug delivery technologies. To this goal, we are working to commercialize a novel polymer platform technology in creating better-in-class ophthalmic drugs and in the broader pharmaceutical space. The novel polymers designed and synthesized using …
DelAQUA Pharmaceuticals
DelAQUA is a specialty pharma that has developed a breakthrough drug formulation technology that (a) reformulates marketed drugs to make them safer and more active and (b) formulates insoluble and unstable new chemical entities to make them safe and bioavailable. …
Codetta Bio
Codetta Bio is advancing and expanding life science research and diagnostic capabilities by providing streamlined, easy-to-use, multiomic, highly multiplexed digital assay solutions. Codetta Bio will set a new standard of multiomic performance and simplicity, enabling customers to gain greater insight …
Elipsys
Elipsys LLC is a sports-focused digital technology company that accelerates performance by uncovering what the athlete is seeing and thinking while they perform. Our patented Quiet EyeTM Training System delivers actionable information in near real-time by combining commercially available eye …
BlueSky Polymers
BlueSky Polymers is developing new chemistries for high-performance polymer material for 3D printing that can be used in both injection molding and composite materials for major industries, including aerospace, automotive, and oil and gas. Founders: Ed Samulski, Theo Dingemans
IrNex
IrNex, Inc., is a University of North Carolina at Chapel Hill startup company formed in August, 2020, in the state of North Carolina. The founders are Qiuhong He, Ph.D. (inventor of the pi-MRSI methods at UNC-CH and other four U.S. …
Predictive
Predictive, LLC’s mission is dedicated to using artificial intelligence and machine learning techniques to understand how pharmaceuticals, chemicals, and personal care products affect people. An area we see that has an unmet need is a software platform that can leverage …
LED Radiofluidics
LED Radiofluidics, Corp. provides the imaging field easy access to cutting edge photoredox labeling technology. One arm of the company will develop simple and low-cost units that could be easily integrated into a commercial box to interface with existing cyclotrons …
OraBiotech
OraBiotech was founded in 2021 by an orthodontist who wanted to provide cutting-edge and effective solutions to people suffering from craniofacial disorders. The company aims to improve the quality of life of patients through innovative therapies. Poor speech can have …
SynchroHealth
SynchroHealth, LLC is an early-stage, small business co-founded by faculty and students from the University of North Carolina (UNC) and Dartmouth College. Our mission is to develop hardware and software solutions for non-invasive detection and acquisition of home-based, longitudinal, healthcare …
SonoVascular
SonoVascular is developing a thrombolysis device for the treatment of blood clots related to deep vein thrombosis, pulmonary embolism and peripheral arterial occlusions. The device utilizes an ultrasound transducer that is small enough to be introduced to the blood vessel …
RainBIO
RainBio is the only ocular gene therapy pioneer focused on blindness in the cornea. Our adeno-associated virus (AAV) vector gene therapy can directly correct cornea cellular function to maintain or restore vision in patients at risk of blindness from a …
CareTriage
CareTriage is a privately held, technology-enabled clinical services startup. The company provides support for value-based care by optimizing medication therapies for complex patients through prescriptive analytics and clinical pharmacist support services. The CareTriage offerings enable healthcare organizations to transition to …
GeneVentiv Therapeutics
GeneVentiv Therapeutics is a pre-clinical gene therapy company focused on blood diseases and disorders. Its lead program, GENV-HEM, is the first universal gene therapy treatment for Hemophilia A and B with or without inhibitors. GENV-HEM has received Orphan Drug Designation …
STAT Apps
STAT Apps is creating an augmented reality video game called Adventure Squad designed for pediatric hospital patients. Through narrative storytelling and augmented reality, the game seeks to get children out of their beds and walking, thereby improving hospital experiences and …
Equiti Foods (formerly GoodBowls)
Equiti Foods is a mission-driven venture focused on food access. Our flagship product line, Good Bowls, is a healthy frozen meal line based on the Mediterranean Diet and adapted for Southern taste preferences. The company is rooted in founder Dr. …
BlackInk Metrics
BlackInk Metrics is an educational software company focused on developing innovative solutions that serves the needs of teachers and students. The company’s lead product is GradingHelp, which promises to deliver a more efficient grading process to writing teachers and to provide …
AI Tracking Solutions
AI Tracking Solutions (AITS) is combining machine learning and artificial intelligence to provide cloud-based, fully automated video tracking analysis software to microscopy community. Their technology focuses on an artificial neural network that can perform convolutions in space and time to …
Triangle Biotechnology
Triangle Biotechnology develops high-throughput, low-cost, user-friendly sonication workflows for biological sample preparation for applications including next-generation sequencing, tissue processing, and cell lysis. Their patented RapidShear® reagents significantly improve the efficiency of sonication-based lysis of biological samples and reduce the energy …
Cymantix
Cymantix is a company established in 2016 and spun-off from the Laboratory of Applied Informatics Research (LAIR) at UNC Chapel Hill’s Carolina Health Informatics Program. The Cymantix team has brought together years of experience in cloud architecture & computing, digital …
SOVE
SOVE is developing an innovative orthodontic system to solve the problems frequently encountered with esthetic orthodontic systems. Current invisible orthodontic systems are uncomfortable, often require removal of healthy enamel to slenderize teeth, have visible components on the front of the …
Sinogate Medbio
Sinogate Medbio specializes in the application of next-generation DNA sequencing for cancer genomics. It has developed AML-MutationCounter as a duplex-consensus NGS test for residual and recurrent leukemia. This test provides oncologists a better measure of residual disease burden following chemotherapy …
Sapere Bio
Sapere Bio is developing a diagnostic test for determining a patient’s “molecular age” that will improve risk assessment and patient outcomes. The company integrates their proprietary sample collection methods, reproducible and precise measurement of senescense biomarkers and development of algorithms …
PrimeNeuro
PrimeNeuro is developing a software solution for the early prediction of Autism Spectrum Disorder (ASD) using objective, MRI-based biomarkers in infants as young as 6 months old. This technology has the potential to greatly improve the quality of life of …
Perotech Corporation
Perotech is developing sensitive X-ray detectors and imaging arrays which are more sensitive, lower cost, compact and easy to use compared to the existing products in the market. Perotech’s X-ray detectors are based on new perovskite materials that enable lower …
LiRA
LiRA is a social venture developing lip-reading technology that employs advancements in computer vision, machine learning, and natural language processing to help voiceless individuals communicate. Founders: Alison Schaefer, Andrew Prince, Dina Yamaleyeva, Andres Tello, Nga Nguyen
BM Polytech
BMPolytech develops and commercializes a new class of materials, tissue-mimetic Brush-like Polymer Networks. This material-design platform developed at UNC-Chapel Hill is based on solvent-free non-leachable materials that precisely replicate the mechanics of biological tissue. Implants made of BMPolytech polymers feel …
Assure Technologies
Assure Technologies, LLC aims to reduce preventable IV medication errors to make all patient care safer and more efficient. Precynge, a medical device developed by Assure Technologies, prevents IV medication errors through highly accurate and precise measurement of medications. Since …
AnelleO
AnelleO is harnessing the advancements in the speed and scale of 3D printing technology for novel solutions in Women’s Health. Intravaginal Rings (IVR) offer a unique platform for sustained delivery of therapeutics – a non-invasive, self-administered and retrievable platform that …
Accunovo Biotechnologies
Accunovo focuses on improvements in early cancer diagnosis. The Company is developing novel targeted PET imaging probes through a combination of unique biomarker-binding molecules and PET imaging molecules for targeted imaging of cancer, allowing earlier diagnosis and treatment. Founder: Rihe …
Aerem Innovations
Aerem Innovations is actively addressing the safety of healthcare workers and members of the community by providing simple yet effective personal protective devices. Our main technology is a mask frame designed to improve the comfort of existing face masks by …
Eldec Pharmaceuticals
Eldec Pharmaceuticals has developed a novel, first-in-class, broad-spectrum, lung-specific immunomodulator called ELD607. ELD607 beneficially normalizes lung neutrophil levels in five different murine lung disease models. By preventing lung-damaging neutrophilia, ELD607 reduces lung damage and increases survival outcomes. In bacterial pneumonia …
IMMvention Therapeutix
IMMvention Therapeutix, based in Durham, NC, is focused on improving the lives of patients with auto-inflammatory diseases of huge unmet needs (such as Osteoarthritis, Gout, Inflammatory Bowel Disease, Alzheimer’s etc.). The company is discovering and developing first-in-class novel disease modifying …
Glycan Therapeutics
Glycan Therapeutics possesses a unique patented technology to synthesize heparin and heparan sulfate oligosaccharides for medical uses. The company is developing new drug therapies based on this novel synthetic carbohydrate technology platform. The platform technology can be used to synthesize …
OncoTrap
OncoTrap is based on identifying drug target binding molecules using in vitro protein selection and protein engineering. The company uses affinity molecules to trap the immunosuppressive signals in the microenvironment of diseased tissues to treat solid tumors and autoimmune diseases. …
Panacise Bio
Panacise Bio is developing technology platforms for next generation Pro-CAR-T-cells, which are activated in the internal tumor microenvironment. These Pro-CAR-T cells can be used for the treatment of various solid tumors. Founder: Rihe Liu
NeuroGT
NeuroGT is focused on development of gene therapy products for treating mucopolysaccharidosis (MPS) disorders and related rare neurogenetic diseases. Founder: Haiyan Fu
GoldCrest Bio
GoldCrest Bio is developing small molecules and novel strains of gut microbiota for treatment of inflammatory diseases. The lead indication is radiation enteritis, a debilitating inflammatory syndrome that affects up to 80 percent of patients receiving abdominal radiotherapy. Currently, the …
Bedrock Therapeutics
Bedrock is an AAV research and development company working on both platform technologies and therapeutic cassettes for diverse genetic diseases. Founders: Matt Hirsch, Chengwen Li, Brian Gilger, Brian Sutton
NabGen
NabGen Inc. is a NC-based biotech company that is removing barriers to gene delivery and human health. Their platform technology functions as a universal antibody suppressant to inhibit anti-drug antibodies and serves as a superior alternative to plasma exchange. NabGen …
EnFuego Therapeutics
A biotech company developing novel RNA interference-(RNAi)-based and antisense oligo therapeutics for “non-druggable” oncogenes such as KRAS. The team has developed therapies that potently bind to mutant KRAS sequences while sparing wild-type KRAS and is optimizing different delivery platforms including …
Mucommune
Mucommune is a privately held company seeking to advance “muco-trapping” monoclonal antibodies for use in reinforcing female reproductive health. The technology is based on engineering the Fc region of IgG antibodies to interact with mucins which enables antibodies to immobilize …
Irex Pharma
Irex Pharma LLC is an early-stage drug discovery company focused on identifying and commercializing innovative therapeutics for respiratory indications where there is unmet medical need. As a UNC startup, Irex Pharma has access to a stellar team of experts in pulmonary …
Epigenos Bioscience
Epigenos Biosciences is focused on developing dCas9 Chemical Epigenetic Modifiers (CEM) -based therapies for multiple rare diseases and cancers driven by single gene mis-regulation (i.e., a gene that is inappropriately turned on or off). Epigenos is developing therapies which combine …
Inhalon Biopharma
Inhalon Biopharma is a clinical-stage immunotherapy company with an inhaled muco-trapping antibody platform to prevent and treat acute respiratory infections. The platform enables inhaled antibodies to trap pathogens in airway mucus, thereby preventing the spread of infection. Trapped pathogens are …
Liquidia Technologies
Liquidia Technologies develops precision-engineered drug particles that have the potential to dramatically improve the performance of medicines. The ability to modify nanoparticle attributes allows Liquidia to develop more optimized safe and effective vaccines and therapies for a wide variety of …
ZeroPoint Dynamics
ZeroPoint Dynamics develops computer and network security products. Their cybersecurity products rapidly analyze e-mail, documents, and web content to prevent data breaches and loss.
Xintek, Inc.
Xintek develops nanomaterial-based field emission technologies and products for a broad range of industries such as x-ray imaging, information display, telecommunication, aerospace and oil detection. Xintek’s major products include: carbon nanotube (CNT)-based field emission electron source, field emission grade CNT …
XinRay Systems
XinRay Systems is a joint venture between Siemens Medical Solutions and Xintek that develops and manufactures distributed x-ray sources for a broad range of applications including diagnostic medical imaging, homeland security, and industrial inspection.
XinNano Materials
XinNano Materials, a joint venture of Xintek, Inc. and TECO Nanotech Col, Ltd., is a world leader in producing high quality carbon nanotubes for field emission, thermal and electrical conducting applications. XinNano Materials has also developed carbon nanotube ink that …
Viamet Pharmaceuticals
Viamet Pharmaceuticals discovered and developed small molecule compounds that targeted metalloenzymes, with applications in fungal infection, oncology, and certain orphan diseases. Viamet Pharmaceuticals was acquired by NovaQuest Capital Management in 2018. Viamet Pharmaceuticals Holdings holds assets not acquired by NovaQuest …
Symberix, Inc.
Company that targets gut bacteria with small molecule therapeutics. The company is advancing a first-in-class approach to improve the treatment of serious lower gastrointestinal (GI) diseases as well as mitigate the debilitating lower GI side effects associated with various cancer, …
StrideBio
StrideBio, Inc. is a gene therapy company focused on creating and developing novel adeno-associated viral (AAV) vector technologies. Our STRucture Inspired DEsign approach holds the potential to generate unique AAV capsids capable of overcoming the challenges of pre-existing neutralizing antibodies …
SonoVol
SonoVol is a life science research tools company, committed to making user-friendly products that accelerate disease research and drug development. Founders: Ryan Gessner, Paul Dayton
Sandbar Oyster Company
Sandbar developed a novel, biodegradable material – Oyster Catcher™ – that promotes oyster growth and restores/creates estuarine habitats. Sandbar is also bringing innovation and core sustainability to oyster aquaculture by offering forms of Oyster Catcher™ and know-how to produce large …
Ribometrix
Ribometrix has developed a proprietary platform for discovering and characterizing the interactions of small molecule drugs that target RNA.
Renovion, Inc.
Renovion is a pre-clinical stage pharmaceutical company with a therapy for chronic inflammatory airway diseases. The company is currently developing Arina-1 as the first FDA-approved therapy for patients who have received a lung transplant and expanding approval into other indications, …
Renaissance Cell Technologies
Renaissance Cell Technologies was developing a liver progenitor cell therapy for treatment of liver failure. The company name was changed to Incara Pharmaceuticals and was later sold to Vesta Therapeutics.
Redbud Labs
Redbud Labs manufactures microfluidic components for life science industry. Redbud’s products improve the performance of microfluidic consumables in research, drug discovery, and diagnostics. The core technology is the patented Redbud Posts™, which enable their cartridge-ready components to deliver enhanced microfluidic …
Qualyst Transporter Solutions
Qualyst Transporter Solutions was a biotechnology company providing hepatic drug transporter models, products and contract research services for accelerating the process of screening drug candidates. Qualyst Transporter Solutions was acquired by BioIVT in 2017.
Pulvinar Neuro
Pulvinar Neuro provides cutting-edge neurotechnology to brain researchers. The company develops and markets a portable device for non-invasive brain stimulation research. Their solution uses transcranial direct current stimulation (tDCS) and transcranial alternating current stimulation (tACS) for brain stimulation. Founder: Flavio …
Premirr Plastics
Using a combination of proprietary chemistry and equipment, Premirr Plastics has developed a new cleantech system to chemically breakdown PET into a reusable starting material (monomers) for new PET products. Unlike traditional recycling methods that melt the plastic into pellets, …
PhoenixSongs Biologicals
PhoenixSongs is a global life science company dedicated to developing and providing novel stem cell-derived model systems for research and drug discovery. Stem cell sources include iPS cells and stem cells isolated from donor tissues such as liver, brain, biliary …
PharmatrophiX
PharmatrophiX is focused on developing small molecule drugs targeting neurotrophin receptors for the treatment of neurodegenerative disorders.
Path BioAnalytics
Path BioAnalytics (PBA) is a precision medicine company dedicated to the advancement of next-generation treatments for individuals living with respiratory disease. PBA couples a personalized 3D cell culture system with extensive in-house clinical datasets from a broad cross-section of individuals …
Parion Sciences
Parion Sciences develops therapies to treat defects of the innate mucosal defense system in respiratory and ocular diseases.
Oriel Therapeutics, Inc.
Oriel Therapeutics develops technology for drug delivery to the lungs to better treat respiratory and pulmonary disease. As of 2010, Oriel Therapeutics was acquired by Sandoz.
Novan, Inc.
Novan, Inc. is a clinical-stage biotechnology company focused on leveraging nitric oxide’s natural antiviral and immunomodulatory mechanisms of action to treat dermatological and oncovirus-mediated diseases.
New Paradigm Biosciences
New Paradigm Biosciences uses a proprietary humanized mouse platform to develop and test therapeutics. This platform allows the study of human specific pathways and the immune system that other in vivo model systems cannot achieve.
Morphormics
Morphormics developed and delivered medical imaging software systems to dramatically increase efficiency and success rate in image-guided medical treatment planning, intervention, and diagnosis. Proprietary image analysis methods were developed that recognized and extracted anatomical structures from 3D and 2D medical …
Mizar Imaging
Mizar Imaging is a modular light sheet illumination system designed for high-resolution imaging. Mounting to most inverted microscopes, the Tilt enables light sheet imaging to be easily added to an existing or new microscope system. Founder: Paul Maddox
Mission3, Inc.
Mission3 is an educational non-profit company distributing an educational software application that tracks medical resident behaviors and skills linked to the ACGME milestones.
KXTbio, Inc.
KXTbio is a biotechnology company focusing on the development and application of reagents, assays and drug screening platforms for the study of G proteins and GTPases with the goal of developing small molecule therapeutics targeting protein-protein interactions.
Meryx, Inc.
Meryx is a biotechnology company developing inhibitors of Mer Receptor Tyrosine Kinase for the treatment of hematologic and solid tumors including leukemia, lung cancer and melanoma.
Altis Biosystems
Altis Biosystems has developed a patent-pending human stem cell platform, which recreates both small and large intestinal tissue for drug screening and microbiome research for pharmaceutical and biotechnology companies. Altis’ technology is high-throughput and produces reproducible results to meet the …
KindHeart, Inc.
KindHeart is a medical-simulation company specializing in surgery simulation systems that use real animal tissue, fully animated surgical simulators.
Inspire Pharmaceuticals, Inc.
Inspire Pharmaceuticals focused on researching, developing, and commercializing prescription pharmaceutical products for ophthalmic and pulmonary diseases. Inspire Pharmaceuticals was acquired by Merck & Co. in 2011.
InnerOptic Technology, Inc.
InnerOptic Technology develops 3D navigation and guidance software for use in minimally invasive image-guided surgical procedures.
Initos Pharmaceuticals
Initos Pharmaceuticals is developing a platform delivery technology for nucleic acid therapeutics to enhance intracellular delivery of oligonucleotides, peptides and proteins to key tissue sites. The technology uses a series of oligonucleotide enhancing compounds (OECs) to enhance the pharmacological activity …
Impulsonic, Inc.
Impulsonic uses high-performance computer graphics techniques and the latest research in acoustics simulation to develop high-performance and accurate acoustics-simulation algorithms for game and virtual reality applications, architects, acoustics consultants, and government and national defense applications. Impulsonic was acquired by Valve …
Hibernaid, Inc.
Hibernaid, Inc. is a pharmaceutical company dedicated to development of medications to treat acute brain injury and other ischemia-reperfusion injuries. Company co-founder Dr. Lawrence Katz studies hypothermia mechanisms and their ability to improve outcomes for critical patients, and the company’s …
GeneCentric Therapeutics
GeneCentric Therapeutics’ proprietary platform utilizes tumor genomic information to enable oncologists and their patients to make informed decisions through clinical trial design, prediction of drug response, drug development target selection and improved therapeutic results.
G1 Therapeutics
G1 Therapeutics is a clinical-stage pharmaceutical company developing small-molecule therapeutic agents to protect patient bone marrow and the immune system from chemotherapy-induced damage.
Ercole Biotech, Inc.
Ercole developed oligonucleotide-based RNA therapeutics that directed alternative splicing of mRNA. These splice-switching drugs represent a new class of drug with the potential to modify gene-encoded proteins and their production. Ercole Biotech was acquired by AVI BioPharma in 2008 and …
Eppin Pharma, Inc.
Eppin Pharma is an emerging pharmaceutical company focused on developing a safe, effective short-term, non-hormonal oral male contraceptive pill. Their lead candidate is a small organic compound, EP055, which binds to EPPIN, a protein on the surface of human sperm, …
Epizyme, Inc.
Epizyme is a clinical stage epigenetics company that is developing small molecule inhibitors of histone methyltransferases for multiple oncology indications.
EpiCypher
EpiCypher develops and manufactures novel tools and reagents for epigenetics drug development and chromatin biology research.
Enzerna Biosciences
Enzerna Biosciences has developed a proprietary platform technology to engineer sequence-specific RNA endonucleases. This technology is designed to treat disease by degrading toxic RNA in a programmable way that is distinct from CRISPR/Cas DNA editing technology. The technology is particularly …
Entegrion
Entegrion develops biological and medical-device technologies to enhance the safety and availability of the human blood supply. Entegrion has developed a lyophilized blood substitute product which is far more stable than stored human platelets and effective at stopping bleeding.
EmpowerRT
Global health social enterprise that provides low cost and simple to use solutions to advance radiotherapy cancer treatments in developing countries. We use the most updated knowledge in the US and creatively maximize the capability of existing resources in developing …
Dualogics
At Dualogics, our vision is to use the latest advancements in protein engineering to create improved antibody therapies. We collaborate globally to bring our technologies and expertise to drug discovery campaigns across all therapeutic areas. Dualogics display uses combinatorial screening …
Counter Tools, Inc.
Counter Tools is a not-for-profit business that provides training, software tools, and technical assistance to public health and disease-prevention organizations.
Cortical Metrics
Cortical Metrics develops quantitative, noninvasive measures of brain health that can address a broad spectrum of neurological disorders.
ChemoGLO
ChemoGLO develops technologies that detect and remove chemotherapy drug contamination in hospitals, pharmacies, and laboratories through its ChemoGLO Wipe Kit and the Hazardous Drug Clean (HDClean) towelette cleaning system.
Cell Microsystems, Inc.
Cell Microsystems develops cell separation and isolation tools. The CellRaftTM technology permits rapid and efficient separation and isolation of single cells.
Asklêpios BioPharmaceutical, Inc. (“AskBio”)
AskBio is advancing AAV gene therapy technologies developed in the Gene Therapy Center at UNC-CH. They have proprietary programs related to AAV capsid development, scaled-up manufacturing, and multiple therapeutic programs in the areas of neuromuscular, CNS and heart diseases.
Aquagenx
Aquagenx provides portable water-quality testing products that detect E. coli bacteria. The Compartment Bag Test is simple to use and does not require complex equipment or electricity, making it ideal for place with fewer resources including developing countries and emergency/disaster …
Capture Pharmaceuticals
Capture Pharmaceuticals has developed a novel chelating compound for the removal of toxic metals, including gadolinium present in MRI contrast agents, lead, and radioactive metals.
Blue Current, Inc.
Blue Current is developing novel materials for improved battery performance.
908 Devices
908 Devices is bringing the powerful capabilities of mass spectrometry out of the confines of centralized laboratories. 908 Devices’ products range from rugged, handheld chemical detection tools to compact, dedicated analyzers for researchers, serving a range of industries including safety …
Bivarus, Inc.
Bivarus develops improved patient satisfaction and experience survey tools. The Bivarus analytics platform utilizes a proprietary statistical framework to generate scientifically valid, real-time data using electronically delivered patient experience surveys. Comprehensive reporting/tracking tools and workspace features facilitate active data management …
Advanced Chemotherapy Technologies
Advanced Chemotherapy Technologies (ACT) is developing an implantable device to infuse chemotherapy drugs directly into the pancreas, targeting difficult-to-reach tumors while largely sparing surrounding tissues, organs and blood vessels. The device, about the size of a quarter, would be implanted …
